Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleCardiology

Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

Zohreh Varasteh, Sarajo Mohanta, Stephanie Robu, Miriam Braeuer, Yuanfang Li, Negar Omidvari, Geoffrey Topping, Ting Sun, Stephan G. Nekolla, Antonia Richter, Christian Weber, Andreas Habenicht, Uwe A. Haberkorn and Wolfgang A. Weber
Journal of Nuclear Medicine December 2019, 60 (12) 1743-1749; DOI: https://doi.org/10.2967/jnumed.119.226993
Zohreh Varasteh
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarajo Mohanta
2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
3German Centre for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Robu
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam Braeuer
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuanfang Li
2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Negar Omidvari
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey Topping
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ting Sun
2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan G. Nekolla
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonia Richter
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Weber
2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
3German Centre for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Habenicht
2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe A. Haberkorn
4Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang A. Weber
1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Experimental timeline. OP = operation.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    In vivo dynamic imaging of 68Ga-FAPI-04 uptake. (A) Serial PET/CT images (axial and coronal sections) from 90-min dynamic scan of MI rat at 7 d after coronary ligation. Representative regions of interest (2-dimensional) drawn over infarct border zone and remote myocardium are illustrated as red and black circles, respectively. Regions of interest in infarcts were placed relatively far from surgical wounds. 68Ga-FAPI-04 exhibited elevated uptake in scars from operation (asterisk). (B) Corresponding time–activity curves for infarcted and noninfarcted heart tissue (average and SD, n = 3). (C) Infarct-to-noninfarct ratio over time (average and SD, n = 3). H = heart; Li = liver; p.i. = after injection.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    In vivo imaging of 68Ga-FAPI-04 uptake in longitudinal study. (A) Static PET/CT matched axial slices in same rat subjected to coronary ligation and scanned 1 h after injection of 68Ga-FAPI-04 (1, 3, 6, 14, 23, and 30 d after MI) and 18F-FDG (3 d after MI). Dashed lines separate tracer uptake in myocardium from uptake in surgical wounds. In 6 d after MI image, representative regions of interest (2-dimensional) drawn over infarct border zone and remote myocardium are illustrated as red and black circles, respectively. 68Ga-FAPI-04 uptake in regions of interest of infarcts is demonstrated. (B) Corresponding time–activity curves for infarcted and noninfarcted heart tissue (average and SD, n = 3). 68Ga-FAPI-04 and 18F-FDG exhibited elevated uptake in scars from operation (asterisk).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Axial sections of in vivo PET/CT imaging with 18F-FDG (day 3 after MI) and 68Ga-FAPI-04 (day 6 after MI) and corresponding ex vivo PET/MRI with 68Ga-FAPI-04 (day 7 after MI). 18F-FDG image was used to identify areas of infarcted myocardium (arrow), where increased uptake of 68Ga-FAPI-04 was apparent (arrowhead). 68Ga-FAPI-04 exhibited elevated uptake in postsurgical scar (asterisk). Dashed line separates 68Ga-FAPI-04 uptake in myocardium from surgical wound. High-resolution MR and PET/MR data confirmed infarcted area, where 68Ga-FAPI-04 uptake was increased.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Binding specificity test. (A) PET/CT axial views, autoradiographs, and corresponding H&E stainings of 10-μm cross-sections prepared from MI nonblocked, blocked, and sham-operated rats. Autoradiographs and H&E stainings from nonblocked hearts show increased 68Ga-FAPI-04 uptake in infarcted area at 7 d after MI, whereas uptake is negligible after sham operation or injection of nonlabeled FAPI-04 (blocked). Infarcted areas in H&E stainings are identified with arrows. (B) PET image–derived infarct-to-noninfarct uptake ratio (derived from 6 nonblocked and 3 blocked rat hearts subjected to coronary ligation). (C) Autoradiography image–derived infarct-to-noninfarct uptake ratio (derived from 3 nonblocked and 3 blocked MI hearts). QL = quantum level.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Ex vivo evaluation of 68Ga-FAPI-04 uptake in infarct at 7 d after MI. Representative autoradiograph and corresponding H&E staining from rat heart show elevated and heterogeneous uptake of 68Ga-FAPI-04 in infarct border compared with infarct center.

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    (A) Tile scan of entire infarcted heart section showing location of FAP+ fibroblasts. Insets 1, 2, and 3 show higher magnification from infarct border, infarct center, and noninfarcted remote myocardium, respectively. (B) Enumeration of FAP+ fibroblast density in MI hearts (n = 3) showing higher FAP+ fibroblast percentage in border zone than in infarct center or remote zone. (C) H&E-stained parallel section. (D) Photomicrographs of FAP, prolyl-4-hydroxylase β (P4H), α-smooth muscle actin, and vimentin-stained infiltrated fibroblasts in periinfarct border zone. Abundant colocalization of FAP, prolyl-4-hydroxylase β, and vimentin shows that accumulated fibroblasts are activated phenotypes, whereas small portion have differentiated into α-smooth muscle actin–positive mature myofibroblasts.

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (12)
Journal of Nuclear Medicine
Vol. 60, Issue 12
December 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04
Zohreh Varasteh, Sarajo Mohanta, Stephanie Robu, Miriam Braeuer, Yuanfang Li, Negar Omidvari, Geoffrey Topping, Ting Sun, Stephan G. Nekolla, Antonia Richter, Christian Weber, Andreas Habenicht, Uwe A. Haberkorn, Wolfgang A. Weber
Journal of Nuclear Medicine Dec 2019, 60 (12) 1743-1749; DOI: 10.2967/jnumed.119.226993

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04
Zohreh Varasteh, Sarajo Mohanta, Stephanie Robu, Miriam Braeuer, Yuanfang Li, Negar Omidvari, Geoffrey Topping, Ting Sun, Stephan G. Nekolla, Antonia Richter, Christian Weber, Andreas Habenicht, Uwe A. Haberkorn, Wolfgang A. Weber
Journal of Nuclear Medicine Dec 2019, 60 (12) 1743-1749; DOI: 10.2967/jnumed.119.226993
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • KEY POINTS
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
  • FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
  • The Latest Developments in Imaging of Fibroblast Activation Protein
  • Targeted PET Imaging of Chemokine Receptor 2-Positive Monocytes and Macrophages in the Injured Heart
  • Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
  • The Future of Nuclear Medicine Depends on the Quality of Its Research: Researchers at the University of Heidelberg Receive the Award for Best Article of the Year
  • The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine
  • CARTing Away Cardiac Fibrosis
  • FAP: The Next Billion Dollar Nuclear Theranostics Target?
  • Google Scholar

More in this TOC Section

Cardiology

  • Imaging of Chemotherapy-Induced Acute Cardiotoxicity with 18F-Labeled Lipophilic Cations
  • Assessment of Myocardial CZT SPECT Recording in a Forward-Leaning Bikerlike Position
Show more Cardiology

Basic

  • Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
  • Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
  • Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Show more Basic

Similar Articles

Keywords

  • myocardial infarction
  • cardiac remodeling
  • Fibroblast Activation Protein
  • Molecular Imaging
  • PET
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire